Latest press releases
- US appeals court issues a temporary injunction pending appeal against distribution of generic PULMICORT RESPULES® (budesonide inhalation suspension)
- 24 May 2013
- Results from Phase III studies of naloxegol for treatment of opioid-induced constipation presented at Digestive Disease Week 2013
- 21 May 2013
- Assessing your asthma is key to taking control
- 13 May 2013
- AstraZeneca PLC first quarter results 2013
- 25 April 2013
- US District Court rules one PULMICORT RESPULES® (budesonide inhalation suspension) patent invalid and another patent not infringed
- 1 April 2013
- AstraZeneca settles litigation over CRESTOR patent
- 25 March 2013
- AstraZeneca to establish strategic R&D center in Gaithersburg, Md; Wilmington remains North America commercial headquarters
- 18 March 2013
- US Court of Appeals affirms decision finding SEROQUEL XR formulation patent valid and infringed
- 14 February 2013
- AstraZeneca encourages atherosclerosis education among high risk patients during American Heart Month
- 14 February 2013